Two Sigma Investments’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $194K | Sell |
170,000
-564,747
| -77% | -$695K | ﹤0.01% | 4288 |
|
|
2025
Q4 | $926K | Sell |
734,747
-520,900
| -41% | -$725K | ﹤0.01% | 2969 |
|
|
2025
Q3 | $1.95M | Sell |
1,255,647
-581,100
| -32% | -$798K | ﹤0.01% | 2144 |
|
|
2025
Q2 | $2.42M | Buy |
1,836,747
+190,972
| +12% | +$261K | ﹤0.01% | 1699 |
|
|
2025
Q1 | $2.73M | Sell |
1,645,775
-1,792
| -0.1% | -$2.95K | 0.01% | 1533 |
|
|
2024
Q4 | $2.42M | Buy |
1,647,567
+949,671
| +136% | +$1.45M | 0.01% | 1587 |
|
|
2024
Q3 | $1.04M | Buy |
697,896
+91,408
| +15% | +$136K | ﹤0.01% | 2097 |
|
|
2024
Q2 | $758K | Sell |
606,488
-1,028,199
| -63% | -$1.33M | ﹤0.01% | 2142 |
|
|
2024
Q1 | $1.96M | Buy |
1,634,687
+665,872
| +69% | +$666K | ﹤0.01% | 1493 |
|
|
2023
Q4 | $1.46M | Sell |
968,815
-471,367
| -33% | -$681K | ﹤0.01% | 1835 |
|
|
2023
Q3 | $2.3M | Sell |
1,440,182
-154,283
| -10% | -$281K | 0.01% | 1294 |
|
|
2023
Q2 | $3.46M | Sell |
1,594,465
-330,009
| -17% | -$516K | 0.01% | 1105 |
|
|
2023
Q1 | $2.81M | Sell |
1,924,474
-344,542
| -15% | -$443K | 0.01% | 1183 |
|
|
2022
Q4 | $2.84M | Sell |
2,269,016
-618,353
| -21% | -$974K | 0.01% | 1132 |
|
|
2022
Q3 | $5.46M | Buy |
2,887,369
+1,191,429
| +70% | +$2.82M | 0.02% | 722 |
|
|
2022
Q2 | $4.29M | Buy |
+1,695,940
| New | +$4.95M | 0.01% | 842 |
|
|
2021
Q4 | – | Sell |
-17,804
| Closed | -$65K | – | 4706 |
|
|
2021
Q3 | $65K | Hold |
17,804
| – | – | ﹤0.01% | 4129 |
|
|
2021
Q2 | $72K | Sell |
17,804
-25,900
| -59% | -$102K | ﹤0.01% | 3933 |
|
|
2021
Q1 | $187K | Buy |
+43,704
| New | +$209K | ﹤0.01% | 3642 |
|
|
2020
Q4 | – | Sell |
-1,107,710
| Closed | -$4.09M | – | 3639 |
|
|
2020
Q3 | $4.09M | Buy |
1,107,710
+59,645
| +6% | +$252K | 0.01% | 894 |
|
|
2020
Q2 | $3.57M | Sell |
1,048,065
-1,861,658
| -64% | -$4.17M | 0.02% | 809 |
|
|
2020
Q1 | $3.9M | Buy |
2,909,723
+347,480
| +14% | +$544K | 0.03% | 620 |
|
|
2019
Q4 | $3.77M | Buy |
2,562,243
+2,398,766
| +1,467% | +$4.02M | 0.01% | 1136 |
|
|
2019
Q3 | $342K | Sell |
163,477
-756,677
| -82% | -$1.55M | ﹤0.01% | 2862 |
|
|
2019
Q2 | $2.25M | Buy |
920,154
+656,802
| +249% | +$1.43M | 0.01% | 1375 |
|
|
2019
Q1 | $687K | Buy |
+263,352
| New | +$797K | ﹤0.01% | 2058 |
|
|
2016
Q4 | – | Sell |
-158,901
| Closed | -$1.68M | – | 3410 |
|
|
2016
Q3 | $1.68M | Buy |
+158,901
| New | +$1.58M | 0.01% | 1592 |
|
|
2016
Q2 | – | Sell |
-15,920
| Closed | -$165K | – | 3140 |
|
|
2016
Q1 | $165K | Buy |
+15,920
| New | +$145K | ﹤0.01% | 2623 |
|
|
2015
Q4 | – | Sell |
-752,431
| Closed | -$6.33M | – | 2901 |
|
|
2015
Q3 | $6.33M | Sell |
752,431
-780,667
| -51% | -$10.3M | 0.03% | 461 |
|
|
2015
Q2 | $24.7M | Buy |
1,533,098
+1,516,803
| +9,308% | +$23.6M | 0.12% | 213 |
|
|
2015
Q1 | $231K | Buy |
+16,295
| New | +$212K | ﹤0.01% | 2430 |
|
Other funds holding OPK
RCMNY
VPM
VCM
WCM
Two Sigma Investments's OPK Position: Q1 2026 in Review
Two Sigma Investments reduced its Opko Health (OPK) stake by 77% in Q1 2026, selling an estimated $695K and leaving 170,000 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #4288.
Two Sigma Investments first reported a position in OPK in Q1 2015 and has held it in 31 quarters since. The position peaked at $24.7M in Q2 2015. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.
- Two Sigma Investments held 170,000 shares of Opko Health worth $194K as of Q1 2026.
- Two Sigma Investments sold 564,747 Opko Health shares in Q1 2026, an estimated $695K.
- Opko Health made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4288 holding.
- Two Sigma Investments first reported a position in Opko Health in Q1 2015 and has held it in 31 quarters since.
- Two Sigma Investments's Opko Health position peaked at $24.7M in Q2 2015.
- 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.